ablation therapy


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia, Wikipedia.

ablation therapy

See Ablation–cardiology.

Patient discussion about ablation therapy

Q. SVT and AF, Hearts that go fast to slow or any others probs with the beats of any kind and Ablation of hearts I have had Ablation done once and I am still having passing out spells and still on 50mg toprol 2 times a day till two days ago, now I am on 150 to 200 aday again. Its not the first time I have had to up meds. I had ablation down 4/22/05. I can breath better now but but it didnt take it away as you can tell. Now Dr Leonardie would like to do it again . This is the big ????! Will it or can it work 100% this time, or will it hit and miss some again???? MTT

A. Well I can understand the frustration of having to go through this procedure yet another time. There are no guarantees in medicine. You should follow your doctor's advice, as another proceudre might be more helpful than the last one. However you should keep in mind that nothing is for sure.

More discussions about ablation therapy
References in periodicals archive ?
Conclusion: RAI ablation therapy in thyroid cancer patients is a safe treatment modality without any serious or persistent hematological side effects.
As one of the leaders in navigation systems and ablation therapy, Biosense Webster, Inc.
The report suggests that DE MRI may identify patients with atrial fibrillation who are not good candidates for ablation therapy because of high fibrosis content within the atrial wall.
The finding that metastatic prostrate cancer responds to androgen- ablation therapy has ushered in a new era in treating prostrate cancer, the second leading cause of death in men.
Patients will receive 2-hour intravenous infusions of 640 mg OGX-011 weekly plus concomitant hormone ablation therapy for 12 weeks prior to radical prostatectomy.
Following ablation therapy, patients resume acid suppression therapy.
Ablation therapy in the management of Meniere's disease.
Based on convincing results from numerous Phase III clinical trials in bone metastases and bone loss due to ablation therapy in prostate cancer patients, Decision Resources forecasts that denosumab (Amgen/GlaxoSmithKline/Daiichi Sankyo's Xgeva/Ranmark) will gain blockbuster status in the cancer pain market by 2016.
The patients could not have received androgen ablation therapy within the previous year.
Although screening, radiation, surgery and hormone ablation therapy have greatly improved the detection and treatment of early stage prostate cancer, few options exist to treat metastatic, castrate-resistant prostate cancer.
CANCER DEMOGRAPHICS BY AGE AND GENDER, 2012 35 ABLATION THERAPY REQUIRES LESS TIME 36 LESS DAMAGE AND BLOOD LOSS 36 RESTRAINTS FOR THE GLOBAL ABLATION DEVICES MARKET 37 PRESSURE FROM REGULATORY AGENCIES 37 INSURANCE SETTLEMENT ISSUES 37 OPPORTUNITIES AND CHALLENGES FOR THE ABLATION DEVICES MARKET 38 GROWING MARKETS IN EMERGING ECONOMIES 38 NEED TO ENHANCE AWARENESS LEVELS 38
Patients will receive ablation therapy with the CryoCor device or other ablation systems approved for treating typical (type 1) atrial flutter and will be followed for 12 months.